A Pesci, GA Rossi, G Bertorelli, A Aufiero, P Zanon and D Olivieri
Istituto di Clinica delle Malattie dell'Apparato Respiratorio dell'Universita di Parma, Italy.

In order to evaluate the degree of mast cell infiltration and determine their granulation state in the airways of patients with chronic bronchitis, bronchoscopy was performed in 25 chronic bronchitis subjects (10 smokers and 15 ex-smokers) with mucoid sputum production and in seven normal nonsmoking control subjects. Bronchoalveolar lavage and bronchial biopsies were examined using histochemical techniques. Subjects with chronic bronchitis had higher numbers of mast cells both in the epithelium (1.22 +/- 1 versus 0.22 +/- 0.2 mast cells per mm) and in the bronchial glands (137.4 +/- 37.9 versus 38 +/- 5.1 mast cells per mm2) than did control subjects (p < 0.01 and p < 0.001, respectively), whereas the numbers of mast cells in bronchoalveolar lavage (0.21 +/- 0.1 versus 0.18 +/- 0.1 mast cells percentage, nonsignificant [NS]) and in the lamina propria (87.5 +/- 66.4 versus 87.2 +/- 61.8 mast cells per mm2, NS) were similar in the two groups. In the smoking group of bronchitics an increase in mast cell numbers was observed in epithelium (1.6 +/- 1.3 versus 0.95 +/- 0.7 mast cells per mm, NS), in lamina propria (112.2 +/- 86.5 versus 71.7 +/- 45.7 mast cells per mm2), and in BAL (0.26 +/- 0.21 versus 0.16 +/- 0.17 mast cell percentage of total cells, NS) in comparison with the ex- smoker's group of bronchitics.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K. F. Chung and I. M. Adcock Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356. [Abstract] [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur. Respir. J., December 1, 2007; 30(6): 1043 - 1056. [Abstract] [Full Text] [PDF]

				E. Gamble, D. C. Grootendorst, K. Hattotuwa, T. O'Shaughnessy, F. S. F. Ram, Y. Qiu, J. Zhu, A. M. Vignola, C. Kroegel, F. Morell, et al. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Eur. Respir. J., September 1, 2007; 30(3): 467 - 471. [Abstract] [Full Text] [PDF]

				J. Zhu, Y. Qiu, M. Valobra, S. Qiu, S. Majumdar, D. Matin, V. De Rose, and P. K. Jeffery Plasma Cells and IL-4 in Chronic Bronchitis and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1125 - 1133. [Abstract] [Full Text] [PDF]

				P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14. [Abstract] [Full Text] [PDF]

				F. Guddo, A. M. Vignola, M. Saetta, S. Baraldo, L. Siena, E. Balestro, R. Zuin, A. Papi, P. Maestrelli, L. M. Fabbri, et al. Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Eur. Respir. J., May 1, 2006; 27(5): 957 - 963. [Abstract] [Full Text] [PDF]

				R O'Donnell, D Breen, S Wilson, and R Djukanovic Inflammatory cells in the airways in COPD Thorax, May 1, 2006; 61(5): 448 - 454. [Abstract] [Full Text] [PDF]

				T S Lapperre, D S Postma, M M E Gosman, J B Snoeck-Stroband, N H T ten Hacken, P S Hiemstra, W Timens, P J Sterk, T Mauad, and on behalf of the GLUCOLD Study Group Relation between duration of smoking cessation and bronchial inflammation in COPD Thorax, February 1, 2006; 61(2): 115 - 121. [Abstract] [Full Text] [PDF]

				B. W. M. Willemse, N. H. T. ten Hacken, B. Rutgers, I. G. A. T. Lesman-Leegte, D. S. Postma, and W. Timens Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Eur. Respir. J., November 1, 2005; 26(5): 835 - 845. [Abstract] [Full Text] [PDF]

				K. Kostikas, M. Gaga, G. Papatheodorou, T. Karamanis, D. Orphanidou, and S. Loukides Leukotriene B4 in Exhaled Breath Condensate and Sputum Supernatant in Patients With COPD and Asthma Chest, May 1, 2005; 127(5): 1553 - 1559. [Abstract] [Full Text] [PDF]

				K. Fujimoto, M. Yasuo, K. Urushibata, M. Hanaoka, T. Koizumi, and K. Kubo Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2005; 25(4): 640 - 646. [Abstract] [Full Text] [PDF]

				B.W.M. Willemse, N.H.T. ten Hacken, B. Rutgers, I.G.A.T. Lesman-Leegte, W. Timens, and D.S. Postma Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD Eur. Respir. J., September 1, 2004; 24(3): 391 - 396. [Abstract] [Full Text] [PDF]

				B.W.M. Willemse, D.S. Postma, W. Timens, and N.H.T. ten Hacken The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation Eur. Respir. J., March 1, 2004; 23(3): 464 - 476. [Abstract] [Full Text] [PDF]

				I.E. Zuhlke, F. Kanniess, K. Richter, D. Nielsen-Gode, S. Bohme, R.A. Jorres, and H. Magnussen Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD Eur. Respir. J., December 1, 2003; 22(6): 926 - 930. [Abstract] [Full Text] [PDF]

				K Amin, A Ekberg-Jansson, C-G Lofdahl, and P Venge Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study Thorax, February 1, 2003; 58(2): 135 - 142. [Abstract] [Full Text] [PDF]

				M J Gizycki, K L Hattotuwa, N Barnes, and P K Jeffery Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue Thorax, September 1, 2002; 57(9): 799 - 803. [Abstract] [Full Text] [PDF]

				N G Carroll, S Mutavdzic, and A L James Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma Thorax, August 1, 2002; 57(8): 677 - 682. [Abstract] [Full Text] [PDF]

				R Polosa, S Rorke, and S T Holgate Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease Thorax, July 1, 2002; 57(7): 649 - 654. [Abstract] [Full Text] [PDF]

				K. L. Hattotuwa, M. J. Gizycki, T. W. Ansari, P. K. Jeffery, and N. C. Barnes The Effects of Inhaled Fluticasone on Airway Inflammation in Chronic Obstructive Pulmonary Disease: A Double-Blind, Placebo-controlled Biopsy Study Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1592 - 1596. [Abstract] [Full Text] [PDF]

				N.G. Carroll, S. Mutavdzic, and A.L. James Distribution and degranulation of airway mast cells in normal and asthmatic subjects Eur. Respir. J., May 1, 2002; 19(5): 879 - 885. [Abstract] [Full Text] [PDF]

				D Miotto, M D Hollenberg, N W Bunnett, A Papi, F Braccioni, P Boschetto, F Rea, A Zuin, P Geppetti, M Saetta, et al. Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers Thorax, February 1, 2002; 57(2): 146 - 151. [Abstract] [Full Text] [PDF]

				C. TAUBE, O. HOLZ, M. MUCKE, R. A. JORRES, and H. MAGNUSSEN Airway Response to Inhaled Hypertonic Saline in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1810 - 1815. [Abstract] [Full Text] [PDF]

				C. E. MAPP, D. MIOTTO, F. BRACCIONI, M. SAETTA, G. TURATO, P. MAESTRELLI, J. E. KRAUSE, V. KARPITSKIY, N. BOYD, P. GEPPETTI, et al. The Distribution of Neurokinin-1 and Neurokinin-2 Receptors in Human Central Airways Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 207 - 215. [Abstract] [Full Text]

				S. R Rutgers, D. S Postma, N. H T ten Hacken, H. F Kauffman, T. W van der Mark, G. H Koëter, and W. Timens Ongoing airway inflammation in patients with COPD who do not currently smoke Thorax, January 1, 2000; 55(1): 12 - 18. [Abstract] [Full Text]

				D. S. POSTMA and H. A. M. KERSTJENS Are Inhaled Glucocorticosteroids Effective in Chronic Obstructive Pulmonary Disease? Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S66 - 71. [Abstract] [Full Text] [PDF]

				W. I. de BOER, A. van SCHADEWIJK, J. K. SONT, H. S. SHARMA, J. STOLK, P. S. HIEMSTRA, and J.H. J. M. van KRIEKEN Transforming Growth Factor beta 1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1951 - 1957. [Abstract] [Full Text] [PDF]

				S. R. RUTGERS, G. H. KOETER, T. W. van der MARK, and D. S. POSTMA Short-term Treatment with Budesonide Does Not Improve Hyperresponsiveness to Adenosine 5'-Monophosphate in COPD Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 880 - 886. [Abstract] [Full Text] [PDF]

				M. SAETTA, G. TURATO, F. M. FACCHINI, L. CORBINO, R. E. LUCCHINI, G. CASONI, P. MAESTRELLI, C. E. MAPP, A. CIACCIA, and L. M. FABBRI Inflammatory Cells in the Bronchial Glands of Smokers with Chronic Bronchitis Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1633 - 1639. [Abstract] [Full Text]